These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10022289)

  • 1. Biochemical and molecular neurotoxicology: relevance to biomarker development, neurotoxicity testing and risk assessment.
    Costa LG
    Toxicol Lett; 1998 Dec; 102-103():417-21. PubMed ID: 10022289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations.
    Costa LG
    Environ Health Perspect; 1996 Mar; 104 Suppl 1(Suppl 1):55-67. PubMed ID: 8722110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of neurotoxicity: research strategies and epidemiological applications.
    Costa LG; Manzo L
    Toxicol Lett; 1995 May; 77(1-3):137-44. PubMed ID: 7618127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell culture models of interspecies selectivity to organophosphorous insecticides.
    Veronesi B; Ehrich M; Blusztajn JK; Oortgiesen M; Durham H
    Neurotoxicology; 1997; 18(1):283-97. PubMed ID: 9216006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant Creutzfeldt-Jakob disease is not associated with individual abilities to metabolise organophosphates.
    Garofalo O; McFarlane EH; Iyegbe C; Whatley SA; Campbell IC; Kopp N; Will RG
    J Neurol Neurosurg Psychiatry; 2001 Oct; 71(4):558-9. PubMed ID: 11561051
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1).
    Furlong CE; Li WF; Richter RJ; Shih DM; Lusis AJ; Alleva E; Costa LG
    Neurotoxicology; 2000; 21(1-2):91-100. PubMed ID: 10794389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
    Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
    Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro techniques for the assessment of neurotoxicity.
    Harry GJ; Billingsley M; Bruinink A; Campbell IL; Classen W; Dorman DC; Galli C; Ray D; Smith RA; Tilson HA
    Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):131-58. PubMed ID: 9539010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current issues in organophosphate toxicology.
    Costa LG
    Clin Chim Acta; 2006 Apr; 366(1-2):1-13. PubMed ID: 16337171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase polymorphisms and organophosphates.
    Worth J
    Lancet; 2002 Sep; 360(9335):802-3. PubMed ID: 12241851
    [No Abstract]   [Full Text] [Related]  

  • 11. New frontiers in delayed neurotoxicity research: introduction and overview.
    Khasawinah AM
    Neurotoxicology; 1983; 4(4):105-6. PubMed ID: 6686865
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview of molecular, cellular, and genetic neurotoxicology.
    Wallace DR
    Neurol Clin; 2005 May; 23(2):307-20. PubMed ID: 15757786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in regulatory requirements for developmental toxicology.
    Kimmel CA; Makris SL
    Toxicol Lett; 2001 Mar; 120(1-3):73-82. PubMed ID: 11323164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic action of organophosphorus compounds and esterase inhibition in houseflies.
    van ASPEREN
    Biochem Pharmacol; 1960 May; 3():136-46. PubMed ID: 13794833
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of organophosphate intoxication on human serum paraoxonase.
    Sözmen EY; Mackness B; Sözmen B; Durrington P; Girgin FK; Aslan L; Mackness M
    Hum Exp Toxicol; 2002 May; 21(5):247-52. PubMed ID: 12141395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and validation of an ontology-driven animal-free testing strategy for developmental neurotoxicity testing.
    Hessel EVS; Staal YCM; Piersma AH
    Toxicol Appl Pharmacol; 2018 Sep; 354():136-152. PubMed ID: 29544899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic considerations of the paraoxonase polymorphisms.
    Furlong CE; Cole TB; Jarvik GP; Costa LG
    Pharmacogenomics; 2002 May; 3(3):341-8. PubMed ID: 12052142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymes involved in the detoxification of organophosphorus, carbamate and pyrethroid insecticides through hydrolysis.
    Sogorb MA; Vilanova E
    Toxicol Lett; 2002 Mar; 128(1-3):215-28. PubMed ID: 11869832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment and neurotoxicology.
    Slikker W
    Curr Protoc Toxicol; 2001 May; Chapter 11():Unit11.6. PubMed ID: 20957643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities.
    Schmidt BZ; Lehmann M; Gutbier S; Nembo E; Noel S; Smirnova L; Forsby A; Hescheler J; Avci HX; Hartung T; Leist M; Kobolák J; Dinnyés A
    Arch Toxicol; 2017 Jan; 91(1):1-33. PubMed ID: 27492622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.